Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- Métastases cérébrales
- | Specialty :
- Radiothérapie et Chimiothérapie
Extract
XERAD: Open-label, phase II, randomized, comparative, multicentre trial of concurrent whole brain radiation therapy (WBRT) and capecitabine (Xeloda® ) followed by maintenance capecitabine compared with standard WBRT in breast cancer patients with newly diagnosed brain metastasis
Scientific Abstract
en cours d'intégration;